Cargando…
Implementation of programmed death-ligand 1 (PD-L1) expression as a prognostic biomarker for patients with lung cancer
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459615/ https://www.ncbi.nlm.nih.gov/pubmed/36090629 http://dx.doi.org/10.21037/tlcr-2022-5 |
| _version_ | 1784786553566920704 |
|---|---|
| author | Li, Huijuan Lin, Dang Lv, Tangfeng |
| author_facet | Li, Huijuan Lin, Dang Lv, Tangfeng |
| author_sort | Li, Huijuan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9459615 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94596152022-09-10 Implementation of programmed death-ligand 1 (PD-L1) expression as a prognostic biomarker for patients with lung cancer Li, Huijuan Lin, Dang Lv, Tangfeng Transl Lung Cancer Res Letter to the Editor AME Publishing Company 2022-08 /pmc/articles/PMC9459615/ /pubmed/36090629 http://dx.doi.org/10.21037/tlcr-2022-5 Text en 2022 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Letter to the Editor Li, Huijuan Lin, Dang Lv, Tangfeng Implementation of programmed death-ligand 1 (PD-L1) expression as a prognostic biomarker for patients with lung cancer |
| title | Implementation of programmed death-ligand 1 (PD-L1) expression as a prognostic biomarker for patients with lung cancer |
| title_full | Implementation of programmed death-ligand 1 (PD-L1) expression as a prognostic biomarker for patients with lung cancer |
| title_fullStr | Implementation of programmed death-ligand 1 (PD-L1) expression as a prognostic biomarker for patients with lung cancer |
| title_full_unstemmed | Implementation of programmed death-ligand 1 (PD-L1) expression as a prognostic biomarker for patients with lung cancer |
| title_short | Implementation of programmed death-ligand 1 (PD-L1) expression as a prognostic biomarker for patients with lung cancer |
| title_sort | implementation of programmed death-ligand 1 (pd-l1) expression as a prognostic biomarker for patients with lung cancer |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459615/ https://www.ncbi.nlm.nih.gov/pubmed/36090629 http://dx.doi.org/10.21037/tlcr-2022-5 |
| work_keys_str_mv | AT lihuijuan implementationofprogrammeddeathligand1pdl1expressionasaprognosticbiomarkerforpatientswithlungcancer AT lindang implementationofprogrammeddeathligand1pdl1expressionasaprognosticbiomarkerforpatientswithlungcancer AT lvtangfeng implementationofprogrammeddeathligand1pdl1expressionasaprognosticbiomarkerforpatientswithlungcancer |